Online psychological support for cancer survivors Mental and Behavioural Disorders
Conditions
Interventions
Randomisation
Prior to the beginning of the study, the Liverpool Clinical Trials Centre will create the randomisation code for the study and set up a randomisation portal to be used by unblinded membe
Sponsors
University of Chester
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Been diagnosed with cancer in the past 6 months 2. Have received anti-cancer treatment with curative intent 3. Aged 16 years or over 4. Sufficiently proficient in English to provide informed consent and use the online programme 5. Able to access the internet 6. Currently have (or willing to set up) an active email address
Exclusion criteria
Exclusion criteria: Severe comorbidity considered by the screening nurse to interfere with the individual’s ability to complete the requirements of the study or provide informed consent (e.g., intellectual disability or neurological impairment)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cancer-specific distress measured by the Post-Traumatic Stress Scale measured at baseline, mid-point assessment, post-treatment assessment, 3-month follow-up assessment, and 6-month follow-up assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Depression, anxiety, and stress measured by the Depression, Anxiety, and Stress Scales – 21 item version (DASS-21) at baseline, mid-point assessment, post-treatment assessment, 3-month follow-up assessment, and 6-month follow-up assessment 2. Quality of life measured by the European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire (version 3.0) (QLQ-C30) at baseline, mid-point assessment, post-treatment assessment, 3-month follow-up assessment, and 6-month follow-up assessment 3. Psychological adjustment to cancer measured by the Psychological Impact of Cancer (PIC) Scale at baseline, mid-point assessment, post-treatment assessment, 3-month follow-up assessment, and 6-month follow-up assessment 4. Health service utilisation measured by the UK Cancer Costs Questionnaire at baseline, mid-point assessment, post-treatment assessment, 3-month follow-up assessment, and 6-month follow-up assessment 5. Social support measured by the MOS Social Support Survey at baseline 6. Vulnerability to distress measured by the Difficulties in Emotion Regulation Scale at baseline 7. Motivation to seek information measured by the Miller Behavioural Style Scale at baseline 8. Psychological flexibility measured by the CompACT at baseline, mid-point assessment, post-treatment assessment, 3-month follow-up assessment, and 6-month follow-up assessment | — |
Countries
England, United Kingdom, Wales
Outcome results
None listed